Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 14/20 | 0.50 |
| ▸ | GGPS1 | O95749 | 8/20 | 0.40 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4828705 | 0.85 | FDPS (0.40) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL4410180 | 0.80 | FDPS (0.37) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL6896476 | 0.70 | FDPS (0.54) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL15438060 | 0.70 | FDPS (0.54) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL11168978 | 0.70 | FDPS (0.54) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL19211961 | 0.69 | FDPS (0.59) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL5247235 | 0.69 | GGPS1 (0.65) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL6293191 | 0.68 | FDPS (0.52) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL1443715 | 0.68 | FDPS (0.52) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL8384760 | 0.68 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9403162-B2 | Ionomers with ionic groups in the side chain | Häring, Thomas (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20150064609-A1 | IONOMERS WITH IONIC GROUPS IN THE SIDE CHAIN | Häring, Thomas (DE) | 2015-03-05 | — | — | US | disclosed |
| US-8742021-B2 | Ionomers with ionic groups in the side chain | Thomas Häring and Rima Häring (DE) | 2014-06-03 | — | — | US | disclosed |
| US-20120245237-A1 | IONOMERS WITH IONIC GROUPS IN THE SIDE CHAIN | HÄRING, Thomas (DE) | 2012-09-27 | — | — | US | disclosed |
| US-20100063168-A1 | IONOMERS WITH IONOGENIC GROUPS IN THE SIDECHAIN | THOMAS HARING | 2010-03-11 | — | — | US | disclosed |
| US-20090259042-A1 | ELECTROCHROMIC COMPOUNDS | NTERA LIMITED (IE) | 2009-10-15 | — | — | US | disclosed |
| US-7567371-B2 | Electrochromic compounds | NTERA LIMITED (IE) | 2009-07-28 | — | — | US | disclosed |
| EP-1786544-A2 | IONOMERS WITH IONOGENIC GROUPS IN THE SIDECHAIN | Häring, Thomas (DE) | 2007-05-23 | — | — | EP | disclosed |
| US-20060110638-A1 | Electrochromic compounds | NTERA LIMITED (IE) | 2006-05-25 | — | — | US | disclosed |
| WO-2006018020-A2 | IONOMERS WITH IONOGENIC GROUPS IN THE SIDECHAIN | Universität Stuttgart (DE) | 2006-02-23 | — | — | WO | disclosed |
| EP-1594938-A1 | ELECTROCHROMIC COMPOUNDS | Ntera Limited (IE) | 2005-11-16 | — | — | EP | disclosed |
| WO-2004067673-A1 | ELECTROCHROMIC COMPOUNDS | NTERA LIMITED (IE) | 2004-08-12 | — | — | WO | disclosed |
| EP-1443091-A1 | Electrochromic compounds | Ntera Limited (IE) | 2004-08-04 | — | — | EP | disclosed |
| EP-0144420-B1 | GUANIDATED AMINOPHOSPHONIC ACID COMPOUNDS | KenoGard AB (SE) | 1987-09-09 | — | — | EP | disclosed |
| US-4600429-A | FUNGICIDE, INSECTICIDES | KENOGARD AB (SE) | 1986-07-15 | — | — | US | disclosed |
| EP-0144420-A1 | GUANIDATED AMINOPHOSPHONIC ACID COMPOUNDS. | KENOGARD AB (SE) | 1985-06-19 | — | — | EP | disclosed |
| WO-1985000038-A1 | GUANIDATED AMINOPHOSPHONIC ACID COMPOUNDS | KENOGARD AB (SE) | 1985-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090259042-A1 | ELECTROCHROMIC COMPOUNDS | ETV6, HCN2, EED | FDPS 3265/4885GGPS1 2741/4885SMPD1 4695/4885 |
| US-20060110638-A1 | Electrochromic compounds | ETV6, HCN2, EED | FDPS 3265/4885GGPS1 2741/4885SMPD1 4695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.